Vaishali Pharma (VAISHALI) Stock Overview

Vaishali Pharma Limited engages in the pharmaceutical business in India and internationally. It offers active pharmaceutical ingredients (APIs), including antibiotics, anti-ulcer, anti-inflammatory/analgesic/anti-pyretic, anti-malarial, cardiac, anti-diabetic, anti-cold/anti-allergic, anti-diarrheal/anti-protozoal/anti-parasitic, anti-viral, anti-epileptic, anti-asthmatic, anti-fungal, anti-platelet agent, skeletal muscle relaxant, and anti-helmintic drugs, as well as excipients, topical steroids, corticosteroids, and enzymes. The company also provides formulation products, such as laxative, anti-ulcer/enzyme, anti-asthmatic, anti-viral, anti-psychotic, vitamins, and other formulations. In addition, it offers veterinary pharmaceutical, nutraceutical, oncology, herbal, and surgical products. Vaishali Pharma Limited was founded in 1989 and is headquartered in Mumbai, India.

VAISHALI Stock Information

Symbol

VAISHALI

Address

706-709, Aravalli Business CenterMumbai, 400092India

Founded

Trading hours

Website

https://www.vaishalipharma.com

Country

🇮🇳 India

Phone Number

91 22 4217 1819

Vaishali Pharma (VAISHALI) Price Chart

Vaishali Pharma Overview: Key Details and Summary

Stock data	2023	Change
Price	$2.47	N/A
Market Cap	$26.07M	N/A
Shares Outstanding	10.55M	0.00%
Employees	27.00	N/A
Shareholder Equity	405.32M	53.80%

Valuation	2023	Change
P/E Ratio	0.42	N/A
P/S Ratio	3.42	N/A
P/B Ratio	0.06	N/A

Growth	2023	Change
Return on Equity	0.0019	N/A

Earnings	2023	Change
Revenue	$7.62M	N/A
Earnings	$788.24K	N/A
EPS	5.91	N/A
Earnings Yield	2.39	N/A
Gross Margin	0.1433	N/A
Operating Margin	0.1406	N/A
Net income margin	0.1035	N/A

Financial Strength	2023	Change
Total Assets	$9.42M	N/A
Total Debt	$1.76M	N/A
Cash on Hand	$1.48M	N/A
Debt to Equity	0.0113	-54.87%
Cash to Debt	0.8431	32.76%
Current Ratio	$2.27	54.00%